Skip to main content

Lynn Grisco

Lynn Grisco is a healthcare executive and strategic advisor with over two decades of leadership across pharmaceuticals, biotechnology, specialty pharmacy, and patient advocacy. She brings expertise in commercial strategy, patient-centered marketing, and access innovation in CNS, oncology, and rare diseases.

Lynn is the founder & CEO of Grisco Consulting, where she partners with healthcare companies to develop transformative strategies that improve patient outcomes & drive market success. She has held senior leadership roles at Acadia, BMS, and Avadel Pharmaceuticals, leading the HCP marketing launch of Lumryz®, a once-nightly treatment for narcolepsy.

Her passion for sleep health deepened when her daughter was diagnosed with narcolepsy in 2022, igniting her role as a dedicated caregiver, advocate, and changemaker in the sleep community.

Lynn serves as Vice Chair, BOD for Wake Up Narcolepsy & on the BOD for the Florida Cancer Specialists Foundation to advance person-centered care.